Patent · US Active

1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives

US10259807B2 · kind B2 · utility

0Cited by

10References

16Claims

0Family size

Assignee

IDORSIA PHARMACEUTICALS LTD · CH

Inventors

Eva Caroff · Allschwil, CH
Emmanuel Meyer · Aarau, CH

Key dates

Filing date	Jul 21, 2014
Grant date	Apr 16, 2019
Priority date	—
Expiry date	Jul 21, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of Formula (I) wherein X, Y, R1, R2, R3, R4 and R5 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.